top of page

Phone:  +918866862020

  • Whatsapp
  • Instagram
  • Facebook
  • X
  • LinkedIn

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Vildanat 50mg Tablet

Vildanat 50mg Tablet

Manufacturer/Marketed By : NATCO PHARMA LTD

$0.67 $0.58

Vildanat 50mg Tablet is an antidiabetic drug that belongs to a class of drugs called dipeptidyl peptidase-4 inhibitors containing the active ingredient Vildagliptin. This medication is indicated in patients with...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

VILDAGLIPTIN

Active Pharmaceutical Ingredient

Vildanat 50mg Tablet

SKU NATCO PHARMA LTD
السعر الأصلي

0.67$

سعر البيع

0.58$

Vildanat 50mg Tablet is an antidiabetic drug that belongs to a class of drugs called dipeptidyl peptidase-4 inhibitors containing the active ingredient Vildagliptin. This medication is indicated in patients with type 2 diabetes mellitus. Type 2 diabetes is a condition in which the blood sugar (glucose) level is high in the body. It occurs when the body cells become resistant to the effect of insulin. As a result of this insulin resistance, the blood glucose level in the body increases. In type 2 diabetes, the body does not make sufficient insulin, or the insulin that is produced is not used well. It is otherwise also known as non-insulin-dependent diabetes mellitus, and since it usually occurs past middle age, it is also widely referred to as mature onset diabetes. If you suspect an allergy to the drug or its components, avoid taking the medicine and consult your doctor. This drug is not recommended in individuals with diabetic ketoacidosis, a serious complication of diabetes caused by high blood sugar and the presence of ketones in the blood. If you are taking an anti-diabetic medicine known as sulphonylurea if you are on dialysis due to kidney problems or liver disease, or if you have had heart failure or a history of pancreatic disease. Your doctor may need to adjust the drug dose when taking it together with Vildanat 50mg Tablet to prevent low blood glucose (hypoglycemia). This drug should not be used during pregnancy unless specifically advised by your physician. Notify your physician if you are pregnant, suspecting, or planning for the pregnancy. It is not known whether Vildanat 50mg Tablet passes into breast milk. You should not use this drug if you are breastfeeding or plan to breastfeed. This medication is not to be taken by children and adolescents under 18. This recommendation is likely due to this age group's limited safety and efficacy data.

Active Pharmaceutical Ingredient

VILDAGLIPTIN

Uses

• Treatment of Type 2 Diabetes mellitus

Benefits

Vildanat 50mg Tablet works by inhibiting the enzyme DPP-4. This enzyme breaks down incretin hormones, which are responsible for increasing insulin release and decreasing glucagon secretion. By inhibiting DPP-4, this drug prolongs the action of incretin hormones, leading to better blood sugar control.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Most Common Side Effects

• Itchy rash
• Trembling
• Headache
• Dizziness
• Muscle pain
• Joint pain
• Constipation
• Excessive sweating
• Vomiting
• Diarrhoea
• Heartburn
• Nausea (feeling sick)
• Blurred vision.

Common Side Effects

• Angioedema
• Liver disease (hepatitis)
• Inflammation of the pancreas (pancreatitis)

How To Use

Take the Vildanat 50mg Tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Safety Advice

• Breast Feeding: It is not known whether Vildanat 50mg Tablet passes into breast milk. If you are breastfeeding or plan to breastfeed, you should not use this drug.
• Alcohol: It is unknown whether consuming alcohol while taking Vildanat 50mg Tablet is safe or not. So, consult your doctor for more information.
• Liver: Vildanat 50mg Tablet should be cautiously administered in patients with severe liver diseases. Inform your physician if you have liver problems before initiating the therapy.
• Lungs: It is unknown whether Vildanat 50mg Tablet is safe for patients with lung problems. Inform your physician if you have lung disease before starting the treatment.
• Driving: If you experience dizziness while taking Vildanat 50mg Tablet, it is important not to drive or operate machinery. Dizziness can impair your ability to perform tasks that require focus and coordination.
• Pregnancy: Vildanat 50mg Tablet should not be used during pregnancy unless specifically advised by your physician. If you are planning to become pregnant or think you may be pregnant, it is essential to consult your doctor before taking this medicine.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page